Last reviewed · How we verify

NCT06591637

Fertility Supportive Behavior Education Based On Watson's Theory Of Human Care

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Fertility supportive behavior education based on Watson's Theory of Human Care in Infertility, Female in 64 participants. Completed in 30 September 2023.

Timeline
5 March 2023
Primary endpoint
15 August 2023
30 September 2023

Quick facts

Lead sponsorTC Erciyes University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment64
Start date5 March 2023
Primary completion15 August 2023
Estimated completion30 September 2023
Sites1 location across Palestinian Territories

Drugs / interventions tested

Conditions studied

Sponsor

TC Erciyes University

Who can join

Adults 18 to 32, female only, with Infertility, Female or IVF. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Infertile individuals frequently attempt behavioral changes to enhance the effectiveness of their treatment and improve fertility outcomes. Consequently, this study was designed to assess the impact of fertility supportive behavior education, grounded in Watson's Human Care Theory, on healthy lifestyle behaviors and the success rates of in vitro fertilization (IVF) in women with primary infertility

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

Other TC Erciyes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06591637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing